BioLine RX Ltd (NASDAQ:BLRX)

3.10
Delayed Data
As of Aug 16
 -0.05 / -1.59%
Today’s Change
2.83
Today|||52-Week Range
27.60
-52.74%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for BioLine RX Ltd have a median target of 18.00, with a high estimate of 26.00 and a low estimate of 10.00. The median estimate represents a +480.65% increase from the last price of 3.10.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in BioLine RX Ltd. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.68
Sales
$100.0K
Reporting Date
Nov 19

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -13.34%
 
 
 
 
 
 
Growthannually 12.56%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.